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Background & aims: The metabolic syndrome is associated with central accumulation of
fat. Previous studies showed that some obese subjects are characterized by a sparing
energy metabolism. The aim of this study was to investigate whether obese subjects with
metabolic syndrome have a lower resting metabolic rate than obese subjects without
metabolic syndrome.
Methods: Forty obese subjects were divided into three groups according to the presence
of metabolic syndrome and type 2 diabetes; 15 non-obese healthy control subjects were
also enrolled. Body composition (bio-impedance analysis) and resting metabolic rate
(indirect calorimetry) were performed.
Results: The group with metabolic syndrome exhibited a significantly lower resting
metabolic rate adjusted for fat-free mass with respect to the control group and the obese
group without metabolic syndrome (respectively: 10873 vs. 11873, po0.01 and
12373 kJ/kg fat-free mass 24 h, po0.01; mean7sem). The obese group with metabolic
syndrome and type 2 diabetes (T2D) had a not different adjusted resting metabolic rate
(11476 kJ/kg fat-free mass 24 h) with respect to other groups.
Conclusions: An energy sparing condition seems to characterize non-diabetic obese
subjects with metabolic syndrome.
& 2007 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights
reserved.Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.
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The metabolic syndrome is invariably associated with
overweight or frank obesity with central distribution of
body fat. Evidences have been accumulated that a sparing
energy metabolism, probably due to genetic factors,
characterizes some obese subjects.1 Resting metabolic rate
(RMR) is the main component of daily energy expenditure,
accounting for about 70% of total daily energy expenditure
in most adult sedentary individuals and it is a predictive
factor for the development of future body weight gain.2,3 A
recent study showed also that RMR variability was associated
with some genetic traits that overlapped regions previously
linked to the metabolic syndrome; furthermore, a significant
association between RMR and metabolic syndrome was
observed.4 Therefore, subjects predisposed to the meta-
bolic syndrome might also be characterized by a lower
energy expenditure that facilitate body weight gain. In the
present study we investigated the RMR in different groups of
obese subjects distinguished on the basis of the presence or
less of the metabolic syndrome with or without diabetes.Materials and methods
Forty obese subjects (24 males, 16 females; range of age:
30–60 years; range of BMI: 30–39.9 kg/m2) were recruited
among the obesity outpatients seen at the Department of
Internal Medicine and Cardiovascular and Kidney Diseases of
the University of Palermo. They were divided into three
groups according to the presence (MS+) or less (MS) of the
metabolic syndrome, with or without type 2 diabetes (T2D).
A group of 15 (9 males and 6 females) normal weight
subjects was also recruited as control. Both diabetes and
hypertension (when these conditions occurred) were diag-
nosed for the first time when subjects were enrolled in the
study. All participants in the study had their body weight
stable for at least the last 3 months and nobody habitually
assumed any drug. Before starting the study, body weightTable 1 Main characteristics of control subjects and obese g
metabolic syndrome (MS) and type 2 diabetes (T2D) (mean7sem
Control M
M/f 9/6
Age (years) 3972
Body weight (kg) 64.872.2 8
BMI (kg/m2) 23.570.5 3
Fat mass (%) 23.671.8 3
Waist circumference (cm) 8572
Systolic blood pressure (mmHg) 10572
Diastolic blood pressure (mmHg) 7271
Blood concentration of:
Total cholesterol (mmol/l) 3.7670.23 4
HDL cholesterol (mmol/l) 1.2470.21 1
Triglycerides (mmol/l) 0.9670.14 0
Significance level vs. control group: apo0.05; bpo0.01; cpo 0.001.
Significance level vs. MS group: dpo0.05; epo0.01.
Significance level vs. MS+ group: fpo0.05.was registered in two occasions with a 7–10 days interval,
subjects whose body weight changed70.5 kg were excluded
from the study. Metabolic syndrome was defined according
to the diagnostic criteria of the NCEP-ATPIII, T2D according
to the criteria of the American Diabetes Association. The
physical and clinical characteristics of the studied groups
are reported in Table 1. The study protocol was approved by
the ethical committee of our institute; before taking part in
the study all subjects were informed of its aims and methods
and gave their voluntary written consent. Each patient was
tested in the morning after about 10 h of overnight fasting. A
blood venous sample was obtained to determine chemical
and C-peptide (radioimmunoassay) data; an oral glucose
tolerance test was performed in all subjects and blood
concentrations of glucose and insulin (radioimmunoassay)
were measured before and 2 h after the assumption of a 75 g
glucose load. The homeostasis model assessment of insulin
resistance (HOMA-IR) was calculated according to Matthews
et al.5 Fat mass (FM, % body weight) and fat-free mass (FFM,
kg) were estimated as previously described6 by means of
bioelectrical impedance analysis (BIA; BIA-103, RJL, Detroit,
USA/Akern Florence, Italy). Body circumferences were
measured at the umbilicus (waist circumference) and at
the most prominent buttock level (hip circumference). The
RMR and the fasting respiratory quotient (RQ; VCO2/VO2: an
indirect measurement of the mixture of carbohydrate and
lipid oxidation) were obtained by means of the indirect
calorimetry method. A ventilated hood system of indirect
calorimetry was employed (2900 MMC, Sensormedics; Yorba
Linda, CA, USA/Bilthoven, The Netherlands). Respiratory gas
exchanges were continuously measured for about 1 h, data
were obtained from at least 30min of stable measurements.
The RMR was expressed both in absolute value (kJ/24 h) and
adjusted for FFM size (kJ/kg-FFM 24 h). Alternatively, due to
the positive intercept in the relationship between RMR and
FFM, a regression-based approach was considered in order to
adjust RMR for FFM size.7
All data are expressed as mean7sem. The statistical
comparisons between the groups were calculated by meansroups defined according to the presence (+) or less () of
).
S MS+ MS+/T2D
9/6 8/5 7/5
4273 4274 4673b
7.473.2c 100.374.3c,d 99.576.0c
1.470.7c 35.070.9c,d 35.371.9c,d
3.972.5c 33.271.9b 33.172.3b
9474a 11672c,d 11974c,d
12278 139710a 15177a
8175 8674a 9175c
.3870.21a 5.3170.52a 5.3970.36b,d
.1770.10 0.8270.08a,d 0.9670.16a,d
.9970.11 1.777 0.42a,d 2.4370.50b,e,f
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Figure 1 Correlation between resting metabolic rate (RMR)
and fat-free mass (FFM).
S. Buscemi et al.808of Student’s unpaired t-test. A p value of less than 0,05 was
considered as statistically significant. The SPSS statistical
software (release 6.0; SPSS Inc.; Chicago, IL, USA) was
utilised to perform all the statistical analysis.
Results
Anthropometric, clinical and biochemical characteristics,
energy expenditure and RQ are reported in Tables 1 and 2.
The RMR in absolute value (kJ/24 h) was significantly
correlated to the FFM-kg (r ¼ 0,84; po0,0001; Figure 1) as
described by the following equation:
RMRðkJ=24 hÞ ¼ 1420þ 21:9FFM-kg.
The RMR, adjusted for FFM according to the Ravussin
procedure (7), was significantly lower in the MS+ group with
respect to the MS group (64727197 vs. 72057193 kJ/24 h;
po0.01); no differences were observed with other studied
groups (control group: 67197101; MS+/T2D: 68497335 kJ/
24 h; p n.s.). A positive correlation between fasting plasma
glucose and RMR adjusted for FFM (kJ/FFM-kg) was observed
in the diabetic group but the statistically significance level
was not reached (r ¼ 0.51; p ¼ 0.07).
Discussion
This study investigated three groups of subjects that were
similar as far as sex distribution, age and anthropometric
characteristics were concerned. However, some differences
need to be pointed out. As expected, the diabetic group was
slightly but significantly older than the control group; both
MS+ and MS+/T2D groups had a significantly higher BMI than
the MS group; body fat size was comparable between the
groups but waist circumference was significantly higher in
the groups with MS. The RMR expressed in absolute value
(kJ/24 h) did not differ between the obese groups, however
it resulted significantly lower in the MS+ group whenTable 2 Basal or after oral glucose (g 75) load blood concent
metabolic rate and respiratory quotient in control subjects and o
of metabolic syndrome (MS) and type 2 diabetes (T2D) (mean7s
Control M
Blood concentration of:
Basal glucose (mmol/l) 4.870.2
2 h post-load glucose (mmol/l) 4.970.2
Basal insulin (pmol/l) 66.076.3
2 h post-load insulin (pmol/l) 279.9750.7 3
Basal C-peptide (mg/ml) 1.8670.17
HOMA-IR 2.0170.24
Resting metabolic rate:
kJ/24 h 58567256
kJ/kg-FFM?24 h 11873
Basal RQ (VCO2/VO2) 0.8770.02
FFM: fat-free mass; RQ: respiratory quotient:
Significance level vs. control group: apo0.05; bpo0.01; cpo 0.001.
Significance level vs. MS group: dpo0.05; epo0.01; fpo 0.001.
Significance level vs. MS+ group: gpo0.05; hpo0.01; ipo 0.001.adjusted for FFM (kJ/FFM-kg 24 h). This result is in
accordance with the hypothesis that obese subjects with
MS have an energy sparing metabolism. The FFM is
commonly considered as the metabolically active body
compartment and it is strongly correlated with RMR.
However, to a lesser extent, other factors are able to
influence the RMR as suggested by the positive intercept
(1420 kJ in this study) of the regression line relating FFM to
RMR. Therefore, it has been proposed to adjust the RMR for
FFM taking into consideration the positive intercept in the
linear regression between these two variables.7 Even when
the RMR was adjusted according to this procedure, the same
conclusions were reached and the MS+ group had arations of glucose, insulin and C-peptide, HOMA-IR, resting
bese groups defined according to the presence (+) or less ()
em).
S MS+ MS+/T2D
4.370.1 5.070.3e 9.370.6c,f,i
5.670.3 9.170.9a,e 14.872.8c,f,h
74.376.3 100.0710.4a,d 147.2722.9c,f,i
52.8743.8 663.2797.9a,d 341.7796.5
2.1970.14 2.7970.15c,e 3.6970.44c,f
2.0370.26 3.2070.34a 8.7971.81c,f,i
70927373b 72267331b 76167423c
12373 10873b,e 11476
0.8270.02 0.7970.02b 0.8770.02d,g
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the same conclusions are obtained even when the RMR is
considered in absolute value. In fact, the RMR expressed in
absolute terms was not significantly different between the
MS and the MS+ groups despite the latter group had a
significantly higher body weigh of about 13 kg.
The value of adjusted RMR in the MS+/T2D group
was about 6% higher than that of the MS+ group and
comparable to that of both the control and the MS groups.
This result is contradictory only in appearance and is in
accordance with previous studies that demonstrated an
increased RMR in diabetic subjects.8 The physiological
mechanisms responsible for the increased RMR in individuals
with T2D are poorly understood and several mechanisms
have been proposed. Gluconeogenesis is increased in T2D
and contributes to hyperglycaemia; this is known to be an
energy-consuming metabolic pathway. The observed posi-
tive correlation between fasting plasma glucose and RMR
(despite the level of significance was not fully reached) is
highly suggestive of this possibility. Diabetic subjects
exhibited a higher RQ with respect to both MS+ and MS
groups thus suggesting a higher post-absorptive glucose
oxidation; this might be a compensatory mechanism that
limits the accumulation of glucose from the enhanced
neoglucogenesis.9
The results of this observational study show that
subgroups of obese subjects different for the presence of
metabolic syndrome or diabetes have a quite different RMR.
Therefore, obesity is not the main element that determine
the decreased energy expenditure of the MS+ group; in this
case, obesity seems, at least in part, the consequence of an
increased energy efficiency. Different pathogenetic mechan-
isms could explain a lower energy expenditure in MS+ obese
subjects including the lipotoxic hypothesis, lower mitochon-
drial levels of uncoupling proteins and genetic polymorphism
in these proteins,10 however they were not investigated in
this study.
In conclusion, these results might contribute to explain
the propensity of subjects affected by MS to obesity. Further
studies are necessary to investigate other components
of energy expenditure and total daily energy expenditure
in subjects with MS. Similarly, the metabolic abnormalities
and underlying mechanisms associated with a lower
energy expenditure in individuals with MS remain to be
elucidated.
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